SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-073821
Filing Date
2024-03-21
Accepted
2024-03-21 16:01:29
Documents
13
Period of Report
2024-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d773925d8k.htm   iXBRL 8-K 26552
  Complete submission text file 0001193125-24-073821.txt   149084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alec-20240315.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20240315_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20240315_pre.xml EX-101.PRE 11254
16 EXTRACTED XBRL INSTANCE DOCUMENT d773925d8k_htm.xml XML 3614
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 24771222
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)